Innovative Journal of Pediatrics
The Scientific Journal of Growth & Development Research Center
Scopus by Title (Ref)
1. Curosurf Versus BLES in the Treatment of Preterm Neonates with Respiratory Distress Syndrome: A Randomized Clinical Trial
- Ostadmohammadi V. , et al.
2. The Care of Preterm and Term Newborns with Respiratory Conditions: A Systematic Synthesis of Evidence from Low- and Middle-Income Countries
- Dominguez G. , et al.
3. A Comparison of the Effect of Beractant (Beracsurf) and Proctant Alpha (Curosurf) in Neonatal Respiratory Distress: A Randomized Controlled Trial
- Najib K.S. , et al.
4. Bioequivalence requirements for orally inhaled and nasal drug products and use of novel physiologically based biopharmaceutics modeling approaches for assessing in vivo performance
- Rachapally A. , et al.
5. A systematic scoping review of the use of surfactant replacement therapy for respiratory distress syndrome in preterm neonates in low- and middle-income countries
- Price C.A. , et al.
7. Comparison of porcine versus bovine surfactant in preterm respiratory distress syndrome: Evidence from real-world data. A multicentre collaboration from Karnataka
- Aradhya A.S. , et al.
8. Targeting neutrophil extracellular traps: A novel strategy in hematologic malignancies
- Liu R. , et al.
9. Comparison of the efficacy of two natural surfactants (BERAKSURF and BLES) in the treatment of respiratory distress syndrome among preterm neonates
- Sabzevari F. , et al.
10. Comparing the clinical and economic efficiency of four natural surfactants in treating infants with respiratory distress syndrome
- Izadi R. , et al.
11. Comparative efficacy of pulmonary surfactant in respiratory distress syndrome in preterm infants: a Bayesian network meta-analysis
- Caihong Q. , et al.
12. Irrational prescription of surfactant replacement therapy in neonatal respiratory distress
- Jahanmehr N. , et al.
13. Clinical observation of different doses of pulmonary surfactant combined with INSURE technology in the treatment of neonatal respiratory distress syndrome
- Feng M. , et al.
14. Excipient Enhanced Growth Aerosol Surfactant Replacement Therapy in an in Vivo Rat Lung Injury Model
- Kamga Gninzeko F.J. , et al.
15. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome
- Ramos-Navarro C. , et al.
16. Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials
- Sánchez Luna M. , et al.
17. Porcine versus bovine surfactant therapy for RDS in preterm neonates: Pragmatic meta-analysis and review of physiopathological plausibility of the effects on extra-pulmonary outcomes
- Foligno S. , et al.
18. Retreatment with surfactant in very low birth weight preterm infants: Risk predictors and their influence on neonatal outcomes
- Ferri W.A.G. , et al.
19. Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials
- Sanchez L.M. , et al.
20. Evaluation of the potential association between cannabinoid receptor 2 gene Q63R polymorphism (Rs35761398) and risk of RDS development in preterm neonates
- Binaafar S. , et al.
21. The Impact of Nonequilibrium Conditions in Lung Surfactant: Structure and Composition Gradients in Multilamellar Films
- Andersson J.M. , et al.